UBS
0A5N.L
LU1169830368
UBS MSCI Switzerland 20/35 UCITS ETF hUSD acc
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
24.38
Weighted Fwd P/E
15.57
Avg P/FCF
27.56
Avg FCF Yield
1.82%
Avg EV / EBITDA
15.68
Avg EV / Revenue
4.1
Avg Price-to-Book (P/B)
6.4
Avg Price-to-Sales (P/S)
3.66
Avg Dividend Yield
0.03%
P/E Compression (Trailing vs Fwd)
-36.12%
Avg Debt-to-Equity (D/E)
107.18%
<50% (15.69%) 50-150% (57.64%) >150% (17.64%) Unreported (9.03%)

Profitability Analysis

39 Holdings Count
Profitable 100%
Profitable 100%
39 Holdings Count (100%)
Unprofitable 0%
0 Holdings Count (0%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

High Concentration (Top-Heavy)
Top 5
56.8%
Top 10
75.3%
Top 25
93.6%
50% Threshold
Top 5
The top 10 holdings account for 75.3% of the total ETF. Performance is heavily driven by a few heavyweights. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

1 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (24.9%+)
High (64.7%+)
Top (89.6%+)

Country Breakdown

Max: 99.56%
CH CH CH
99.56%

Sector Distribution

10 Sector
Healthcare
37.74%
Financial Services
20.29%
Consumer Defensive
13.90%
Industrials
12.78%
Consumer Cyclical
6.50%
Basic Materials
5.92%
Other
2.43%

Industry Distribution

25 Industries
Drug Manufacturers - General
28.71%
Packaged Foods
13.08%
Insurance - Diversified
8.05%
Banks - Diversified
7.87%
Electrical Equipment & Parts
7.79%
Luxury Goods
6.21%
Drug Manufacturers - Specialty & Generic
3.69%
Specialty Chemicals
3.67%
Other
20.50%

Market Cap Distribution

39 Holdings Count
Mega Cap (> 200B)
(4) 41.78%
Large Cap (10B - 200B)
(31) 56.73%
Mid Cap (2B - 10B)
(4) 1.05%
ende